Propdo in the First Quarter: The Pipeline Grew, but Sales Quality and Funding Still Set the Test

Propdo opened 2026 with a two-sided message: the development platform is more active than before, but the route to accessible cash still runs through funding, sales terms, and the pace at which projects move from planning into execution. Revenue fell to NIS 4.2 million in the quarter, the loss attributable to shareholders was NIS 8.3 million, and operating cash flow was negative NIS 28.8 million. On the other hand, equity attributable to shareholders rose to NIS 18.2 million after warrant exercises, and after the balance-sheet date the company added a bond expansion, a private placement, and a controlling-shareholder support framework. The quarter does not contradict the prior annual read of a large project pool with a continuing funding burden. It sharpens it: the question is no longer only whether the pipeline exists, but under what sales terms it is sold, how much capital it consumes on the way, and when project surplus can move up to the public-company layer. The less obvious datapoint is that first-quarter sales included payment deferrals, building-cost-index relief, and developer-loan structures. That does not erase demand, but it changes the quality of growth: part of the pace is being supported by customer relief and interim funding, so the next reports need to show not just more projects, but also better cash conversion and margin protection after those concessions.

The Company Is a Regeneration Platform Before the Cash Stage

The company now operates almost entirely in residential development in Israel, mainly urban renewal. The proptech activity was frozen from the end of 2024 and is not an economic engine in the current quarter. The right way to understand the company is therefore not through a mature developer’s revenue line, but through three stages: obtaining rights and signatures, arranging finance and project lending, and then execution, deliveries, and surplus release.

That model can create a large opportunity, but it also creates a large gap between pipeline numbers and cash accessible to shareholders. The quarterly pipeline table includes 78 projects and 9,195 units for sale across the group. Only 12 projects and 209 units for sale are currently in execution and marketing. Most of the reported value sits in planning and initiation: 28 projects, 8,074 units for sale, and about NIS 2.29 billion of remaining project surplus on the company’s pre-option share.

This gap matters especially after the prior annual analysis, where the pipeline was the strong side and funding, execution, and surplus release were the open questions. In the first quarter, equity attributable to shareholders improved from NIS 5.4 million at the end of 2025 to NIS 18.2 million. Still, consolidated equity of NIS 42.1 million includes non-controlling interests, while the parent company itself ended the quarter with only NIS 2.0 million of cash and cash equivalents. That is why the issue is not whether project value exists, but how much of it can cross the funding, minority-interest, and option layers.

The same table also includes a more optimistic layer: assuming full option exercise, the company’s share of remaining project surplus rises to about NIS 4.08 billion. But the disclosure also says this figure assumes option exercises in Yushpa, GLM, Rom, and Midar, and that project surplus is shown before bond repayment, non-project liabilities, headquarters expenses, and corporate tax. The large number is useful analytical material, not accessible cash.

Sales Exist, but the Terms Matter More Than the Count

First-quarter revenue was NIS 4.246 million, down about 41% from NIS 7.204 million in the comparable quarter. Most of the revenue came from GLM, mainly from the Arlozorov project in Bat Yam. The reported gross loss was NIS 969 thousand, but the same accounting distinction from the prior work on the accounting gap still applies: excluding NIS 1.511 million of excess-cost amortization recorded after the sale of the small Hamorad 3 project in Givatayim, gross profit would have been about NIS 542 thousand.

That does not make the quarter strong. It means the reported gross line is still mixing project activity with the purchase-accounting cost of prior acquisitions. The more important issue this quarter is not only lower revenue, but the quality of new sales. The company gives a sharper view of how much of the marketing activity is being supported by commercial concessions.

This is where the quarter adds value beyond a revenue recap. In residential development, a sale with broad indexation relief or deferred payment is not the same as a sale on normal terms. It may be a rational commercial decision to support marketing and unlock financing, but the cost sits in working capital, margin, and construction-cost exposure. If market conditions let the company reduce these concessions in the next few quarters, this quarter will look like a reasonable acceleration phase. If the concessions become a permanent sales tool, the pipeline can grow while earnings quality remains less clean.

The Quarter Was Funded, Not Solved

All-in cash flexibility after the quarter’s real cash uses was tight. This is not a normalized cash-generation measure for the existing business. It is the cash left after operating cash flow, investing activity, repayments, new borrowings, and warrant exercises. On a consolidated basis, operating activity consumed NIS 28.8 million. Investing activity consumed another NIS 5.0 million. Financing activity contributed NIS 28.2 million, mainly NIS 20.7 million from warrant exercises and NIS 14.9 million from new borrowings, offset by repayments and loan returns.

The cash-flow statement shows where the money went: NIS 14.5 million into inventory, buildings under construction and land rights, NIS 6.7 million through lower payables and other credit balances, and NIS 3.3 million in interest paid. In business terms, the company is still financing the transition from pipeline to execution. That is normal for an early-stage urban-renewal developer, but it is also the bottleneck: until surplus from mature projects is released, the public-company layer needs equity, debt, and controlling-shareholder support.

After the balance-sheet date, three financing reinforcements arrived: a bond expansion with gross proceeds of about NIS 17.2 million, a private placement for about NIS 16.7 million, and an updated controlling-shareholder commitment to provide loans of up to NIS 60 million for 24 months after the company exhausts other funding options. These moves reduce near-term pressure, but they also confirm the friction point. The company is not yet funding its progress mainly from surplus already released from projects. It is doing so through a mix of capital markets access, debt, project-level facilities, and controlling-shareholder support.

The Series A bond covenant explains why consolidated equity matters: consolidated equity must not fall below NIS 20 million, and at the end of the quarter it was about NIS 42 million. That is comfortable against the covenant, but it is not the same as equity attributable to shareholders, which was NIS 18.2 million. In addition, the company cannot make distributions until the bonds are fully repaid. The market can take some comfort from the financing framework, but it should not confuse covenant compliance with value already released to shareholders.

The Pipeline Grew Mainly in Layers Still Far From Execution

The quarter and post-quarter events added several business milestones. Bnei Haneviim received in February a credit facility of up to about NIS 110 million for construction. Yushpa received at the end of March a NIS 50 million credit facility for current needs. Zhabotinsky 15 in Givatayim received after the balance-sheet date a credit facility of up to about NIS 167.8 million for construction. These are not just pipeline figures. They are movement toward execution or funding capacity.

At the same time, Propdo Carasso, which holds Yushpa and is accounted for under the equity method, still shows the complexity. Its first-quarter revenue rose to NIS 30.4 million from NIS 23.2 million in the comparable quarter, but it still lost NIS 5.6 million. That loss includes NIS 4.7 million of interest expense. In other words, even when the project layer outside consolidation generates revenue, it is still not producing profit that lifts clean value into the parent-company accounts.

The Shani Eliyahu filing in Ashkelon adds another example of the gap between the size of a right and the economic distance. The company reached the required majority in a project where 128 existing apartments are expected to become about 726 units, of which about 598 are for sale. The preliminary project numbers are large: expected revenue of about NIS 1.30 billion, expected gross profit of about NIS 259 million, and project surplus of about NIS 355 million. But execution is expected to start only in the fourth quarter of 2031, completion only in the fourth quarter of 2036, equity not yet invested is estimated at NIS 166.7 million, and the structure relies on an economic-completion subsidy whose existence, amount, terms, and timing are not certain.

That is not a reason to ignore the project. It does change the weight it should receive in the current quarter. Shani Eliyahu increases the option set, but it does not answer the more urgent 2026 question: whether projects already in execution or close to execution can generate sales on reasonable terms, obtain lending, and begin releasing surplus without requiring more capital layers on the way.

Conclusion

The first quarter reinforces the view that Propdo is a pipeline-and-funding story more than a quarterly earnings story. The positive side is clear: equity improved, controlling shareholders and capital markets supplied new sources, several projects received credit facilities, and the company reported no sales cancellations. The less comfortable side is that cash flow is still negative, part of the sales activity is being supported by commercial concessions, and most project surplus sits in layers still far from execution or dependent on option exercise and further funding.

From here, the market is likely to measure the company by three near-term tests. The first is sales quality: whether payment deferrals, indexation relief, and developer loans remain tactical tools or become the regular way to maintain pace. The second is the move from financed project to surplus-generating project, mainly at Arlozorov, Bnei Haneviim, Zhabotinsky, and Yushpa. The third is the parent-company layer: whether the new funding buys time until project cash is released, or whether the company keeps consuming new capital before the project economics reach shareholders.

The strongest counter-thesis is that this caution may miss a platform exactly at the stage where cash flow is supposed to look expensive. If customer concessions remain controlled, interest rates ease, and financed projects move faster into execution and sales, today’s losses may turn out to be the cost of building a large project pool. The current quarter still does not prove that. It gives the company time, pipeline, and financing progress, and asks readers to watch whether that time starts turning into cash in the coming quarters.